These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1664429)

  • 1. Immobilization of Fv antibody fragments on porous silica and their utility in affinity chromatography.
    Berry MJ; Davies J; Smith CG; Smith I
    J Chromatogr; 1991 Dec; 587(2):161-9. PubMed ID: 1664429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antibody fragments in immunoaffinity chromatography. Comparison of FV fragments, VH fragments and paralog peptides.
    Berry MJ; Davies J
    J Chromatogr; 1992 Apr; 597(1-2):239-45. PubMed ID: 1517323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of lysozyme with synthetic anti-lysozyme D1.3 antibody fragments studied by affinity chromatography and surface plasmon resonance.
    Lasonder E; Bloemhoff W; Welling GW
    J Chromatogr A; 1994 Jul; 676(1):91-8. PubMed ID: 7921183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nanogold- and fluorescent-labeled antibody Fv fragments in immunocytochemistry.
    Ribrioux S; Kleymann G; Haase W; Heitmann K; Ostermeier C; Michel H
    J Histochem Cytochem; 1996 Mar; 44(3):207-13. PubMed ID: 8648079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of dissociation between antibody and antigen determines the efficiency of antibody-mediated antigen presentation to T cells.
    Guermonprez P; England P; Bedouelle H; Leclerc C
    J Immunol; 1998 Nov; 161(9):4542-8. PubMed ID: 9794380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in the amide hydrogen exchange rates of an anti-lysozyme Fv fragment due to formation of the Fv-lysozyme complex.
    Williams DC; Rule GS; Poljak RJ; Benjamin DC
    J Mol Biol; 1997 Aug; 270(5):751-62. PubMed ID: 9245602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A.
    Ito W; Kurosawa Y
    J Biol Chem; 1993 Sep; 268(27):20668-75. PubMed ID: 8376416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of immunoadsorbents comprising antibody fragments. Comparison of Fv fragments and single-chain Fv fragments.
    Berry MJ; Pierce JJ
    J Chromatogr; 1993 Jan; 629(2):161-8. PubMed ID: 8429079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Fv fragments expressed on phage surface.
    Ito W; Kurosawa Y
    J Biochem; 1998 May; 123(5):832-8. PubMed ID: 9562613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ten-residue fragment of an antibody (mini-antibody) directed against lysozyme as ligand in immunoaffinity chromatography.
    Welling GW; van Gorkum J; Damhof RA; Drijfhout JW; Bloemhoff W; Welling-Wester S
    J Chromatogr; 1991 Jul; 548(1-2):235-42. PubMed ID: 1939424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of FV and Fab fragments of the antibody McPC603 expressed in E. coli.
    Plückthun A; Glockshuber R; Skerra A; Stadmüller J
    Behring Inst Mitt; 1990 Dec; (87):48-55. PubMed ID: 2096820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity-reversed-phase liquid chromatography assay to quantitate recombinant antibodies and antibody fragments in fermentation broth.
    Battersby JE; Snedecor B; Chen C; Champion KM; Riddle L; Vanderlaan M
    J Chromatogr A; 2001 Aug; 927(1-2):61-76. PubMed ID: 11572399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of affinity changeable antibody in response to Ca2+.
    Kobatake E; Kosaku C; Hanzawa S; Mie M
    Biotechnol Lett; 2012 Jun; 34(6):1019-23. PubMed ID: 22350334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity separation using an Fv antibody fragment-"smart" polymer conjugate.
    Fong RB; Ding Z; Hoffman AS; Stayton PS
    Biotechnol Bioeng; 2002 Aug; 79(3):271-6. PubMed ID: 12115415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of E. coli tryptophan synthase by single-chain Fv fragments: comparison of PCR-cloning variants with the parental antibodies.
    Brégégère F; England P; Djavadi-Ohaniance L; Bedouelle H
    J Mol Recognit; 1997; 10(4):169-81. PubMed ID: 9476520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-immobilizing recombinant antibody fragments for immunoaffinity chromatography: generic, parallel, and scalable protein purification.
    Blank K; Lindner P; Diefenbach B; Plückthun A
    Protein Expr Purif; 2002 Mar; 24(2):313-22. PubMed ID: 11858727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered Fv fragments as a tool for the one-step purification of integral multisubunit membrane protein complexes.
    Kleymann G; Ostermeier C; Ludwig B; Skerra A; Michel H
    Biotechnology (N Y); 1995 Feb; 13(2):155-60. PubMed ID: 9634756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay and purification of Fv fragments in fermenter cultures: design and evaluation of generic binding reagents.
    Berry MJ; Wattam TA; Willets J; Lindner N; de Graaf T; Hunt T; Gani M; Davis PJ; Porter P
    J Immunol Methods; 1994 Jan; 167(1-2):173-82. PubMed ID: 7508476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Diabodies": small bivalent and bispecific antibody fragments.
    Holliger P; Prospero T; Winter G
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.